89 related articles for article (PubMed ID: 17711507)
1. Biological and therapeutic significance of MUC1 with sialoglycans in clear cell adenocarcinoma of the ovary.
Tamada Y; Takeuchi H; Suzuki N; Susumu N; Aoki D; Irimura T
Cancer Sci; 2007 Oct; 98(10):1586-91. PubMed ID: 17711507
[TBL] [Abstract][Full Text] [Related]
2. Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma.
Masaki Y; Oka M; Ogura Y; Ueno T; Nishihara K; Tangoku A; Takahashi M; Yamamoto M; Irimura T
Hepatogastroenterology; 1999; 46(28):2240-5. PubMed ID: 10521973
[TBL] [Abstract][Full Text] [Related]
3. Subcellular localization of MUC1 recognized by a monoclonal antibody MY.1E12 correlates with postsurgical prognosis in differentiated-type gastric carcinomas of stage II and III.
Shinozaki E; Adachi S; Shoda J; Kawamoto T; Suzuki H; Irimura T; Ohkohchi N
Int J Oncol; 2004 Nov; 25(5):1257-65. PubMed ID: 15492813
[TBL] [Abstract][Full Text] [Related]
4. A synthetic retinoid, TAC-101 (4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid), plus cisplatin: potential new therapy for ovarian clear cell adenocarcinoma.
Ezawa S; Suzuki N; Ohie S; Higashiguchi A; Hosoi F; Kitazato K; Susumu N; Aoki D
Gynecol Oncol; 2008 Mar; 108(3):627-31. PubMed ID: 18048092
[TBL] [Abstract][Full Text] [Related]
5. Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.
Kawamoto T; Shoda J; Irimura T; Miyahara N; Furukawa M; Ueda T; Asano T; Kano M; Koike N; Fukao K; Tanaka N; Todoroki T
Clin Cancer Res; 2001 May; 7(5):1333-42. PubMed ID: 11350903
[TBL] [Abstract][Full Text] [Related]
6. Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance.
Wang L; Ma J; Liu F; Yu Q; Chu G; Perkins AC; Li Y
Gynecol Oncol; 2007 Jun; 105(3):695-702. PubMed ID: 17368732
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin, epirubicin, and ifosfamide versus cisplatin, epirubicin, and cyclophosphamide in clear cell carcinoma of the ovary.
Nishida T; Sugiyama T; Yakushiji M
Gynecol Oncol; 1997 Nov; 67(2):230. PubMed ID: 9367714
[No Abstract] [Full Text] [Related]
8. A calicheamicin conjugate with a fully humanized anti-MUC1 antibody shows potent antitumor effects in breast and ovarian tumor xenografts.
Hamann PR; Hinman LM; Beyer CF; Lindh D; Upeslacis J; Shochat D; Mountain A
Bioconjug Chem; 2005; 16(2):354-60. PubMed ID: 15769089
[TBL] [Abstract][Full Text] [Related]
9. A novel monoclonal antibody specific for sialylated MUC1 mucin.
Yamamoto M; Bhavanandan VP; Nakamori S; Irimura T
Jpn J Cancer Res; 1996 May; 87(5):488-96. PubMed ID: 8641986
[TBL] [Abstract][Full Text] [Related]
10. HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells.
Suzuki N; Aoki D; Tamada Y; Susumu N; Orikawa K; Tsukazaki K; Sakayori M; Suzuki A; Fukuchi T; Mukai M; Kojima-Aikawa K; Ishida I; Nozawa S
Gynecol Oncol; 2004 Nov; 95(2):290-8. PubMed ID: 15491748
[TBL] [Abstract][Full Text] [Related]
11. PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma.
Gold DV; Karanjawala Z; Modrak DE; Goldenberg DM; Hruban RH
Clin Cancer Res; 2007 Dec; 13(24):7380-7. PubMed ID: 18094420
[TBL] [Abstract][Full Text] [Related]
12. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of elongation factor eEF1A2 in ovarian cancer.
Pinke DE; Kalloger SE; Francetic T; Huntsman DG; Lee JM
Gynecol Oncol; 2008 Mar; 108(3):561-8. PubMed ID: 18164751
[TBL] [Abstract][Full Text] [Related]
14. For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?
Dizon DS; Restivo A; Lomme M; Charbonneau N; Brard L; Hughes T; Weitzen S; Legare R; Granai CO; Disilvestro P
Am J Clin Oncol; 2008 Feb; 31(1):39-42. PubMed ID: 18376226
[TBL] [Abstract][Full Text] [Related]
15. Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer.
Cramer DW; Titus-Ernstoff L; McKolanis JR; Welch WR; Vitonis AF; Berkowitz RS; Finn OJ
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1125-31. PubMed ID: 15894662
[TBL] [Abstract][Full Text] [Related]
16. Staining of MUC1 in ovarian cancer tissues with PankoMab-GEX detecting the tumour-associated epitope, TA-MUC1, as compared to antibodies HMFG-1 and 115D8.
Dian D; Lenhard M; Mayr D; Heublein S; Karsten U; Goletz S; Kuhn C; Wiest I; Friese K; Weissenbacher T; Jeschke U
Histol Histopathol; 2013 Feb; 28(2):239-44. PubMed ID: 23275306
[TBL] [Abstract][Full Text] [Related]
17. Expression of the DF3-P epitope in human ovarian carcinomas.
Ichige K; Perey L; Vogel CA; Buchegger F; Kufe D
Clin Cancer Res; 1995 May; 1(5):565-71. PubMed ID: 9816017
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: a potential treatment strategy.
Sato S; Itamochi H; Kigawa J; Oishi T; Shimada M; Sato S; Naniwa J; Uegaki K; Nonaka M; Terakawa N
Cancer Sci; 2009 Mar; 100(3):546-51. PubMed ID: 19154404
[TBL] [Abstract][Full Text] [Related]
19. Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer.
Budiu RA; Mantia-Smaldone G; Elishaev E; Chu T; Thaller J; McCabe K; Lenzner D; Edwards RP; Vlad AM
Cancer Immunol Immunother; 2011 Jul; 60(7):975-84. PubMed ID: 21461842
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity.
Giuntoli RL; Webb TJ; Zoso A; Rogers O; Diaz-Montes TP; Bristow RE; Oelke M
Anticancer Res; 2009 Aug; 29(8):2875-84. PubMed ID: 19661290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
